Bruce Cutter
Medical Oncology · Spokane Valley, WANPI 1356337349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $814 and has fallen 95.7% since, to $35 in 2025. That places this record below the midpoint for medical oncology clinicians in WA, where the typical reported total is $2,355.
Across 73 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$209
- Pfizer$139
- Amgen$106
- Genentech USA, Inc.$82
- Gilead$63
- AstraZeneca$56
- plus $566 from 18 others
What the payments were for
- Food & beverage$1,18797%
- Education$343%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $209 |
| Pfizer | 14 | $139 |
| Amgen | 5 | $106 |
| Genentech USA, Inc. | 5 | $82 |
| Gilead | 4 | $63 |
| AstraZeneca | 3 | $56 |
| Astellas Pharma US Inc | 3 | $55 |
| Lilly USA, LLC | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $38 |
| Eisai Inc. | 2 | $37 |
| Merck | 2 | $37 |
| Seagen Inc. | 2 | $35 |
| AbbVie | 1 | $35 |
| Bristol Myers Squibb | 2 | $33 |
| Sanofi | 2 | $27 |
| Coherus Oncology, Inc. | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Array Biopharma Inc | 1 | $15 |
| Dova Pharmaceuticals | 1 | $11 |
How this compares
$1,221 in reported general payments places this provider in the 40th percentile of 162 medical oncology providers in Washington.
Other medical oncology in Spokane Valley
- Hakan KayaSpokane$2.2M
- Bart ScottSeattle$1.3M
- William BensingerLakewood$1.2M
- Petros GrivasSeattle$628K
- Vijayakrishna GadiSeattle$573K
- Evan YuSeattle$296K
- Siddhartha DevarakondaSeattle$215K
- David MaloneySeattle$150K
- Gary LymanSeattle$130K
- Joseph YeOlympia$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.